Harry Irving, Hung Jiew Lee, John Parratt

Slides:



Advertisements
Similar presentations
Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis.
Advertisements

Autoimmunity and Type I Diabetes CCMD 793A: Fundamental Integrated SystemsFALL, 2006 James M. Sheil, Ph.D.
Date of download: 6/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Quantification and Functional Characterization of.
Yael Hacohen, Kshitij Mankad, W
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease  C Bjartmar, J.R Wujek, B.D Trapp  Journal of.
Four Known Types of MS Clinically isolated syndrome (CIS)
Chlamydia pneumoniae-specific CSF-restricted oligoclonal IgG bands are associated to a subset of patients with progressive forms of Multiple Sclerosis.
Copyright © 2010 American Medical Association. All rights reserved.
Expression of Snail1 correlates with the level of LSD1 and CoREST in tumour tissues. Expression of Snail1 correlates with the level of LSD1 and CoREST.
Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury by Wenjie Wang, Costas J. Schulze, Wilma.
Belle Huffman Biology 430 Dr. Spilatro
CD46: role in multiple sclerosis
Volume 18, Issue 1, Pages (February 2011)
Figure 1. Absence of anti–neurofascin-155 (NF155) antibodies in combined central and peripheral demyelination (CCPD)‏ Absence of anti–neurofascin-155 (NF155)
Nat. Rev. Neurol. doi: /nrneurol
Figure Model contrasting the potential role of antibodies to myelin oligodendrocyte glycoprotein (MOG) or aquaporin-4 (AQP4) in opticospinal inflammationMOG-specific.
Roopa Bhat, Lawrence Steinman  Neuron 
Supplementary Figure 2 Secondary transplanted brain tumors from PASC1 express human GH. Immuno-fluorescence staining of brain sections from mice implanted.
RED BLOOD CELLS.
Figure 4 Neuromyelitis optica spectrum disorder brain lesions
Figure 2 Orbital MRI findings One-third of myelin oligodendrocyte glycoprotein antibody–positive patients revealed extensive enhancement patterns that.
Figure 3 Antibodies to MOG using different secondary antibodies: Anti-human IgG (H + L), IgG1, or IgM(A) Comparison of binding to full-length myelin oligodendrocyte.
Figure 1 Percent positivity by clinical feature Overall, 6
Figure 2 Temporal distribution of MOG antibody in serum of 2 relapsing patients with demyelinating diseases Temporal distribution of MOG antibody in serum.
Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats  K. Thelle, E.I. Christensen, H. Vorum,
Pathogenic Epitopes of Autoantibodies in Pemphigus Reside in the Amino-Terminal Adhesive Region of Desmogleins Which Are Unmasked by Proteolytic Processing.
Carlton M. Bates, Heather Kegg, Christina Petrevski, Sandy Grady 
Volume 83, Issue 4, Pages (April 2013)
Figure 1 Neuromyelitis optica spectrum disorder (NMOSD) subgroups and patients with relapsing-remitting multiple sclerosis (RRMS) show different antibody.
Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells  Hanne B. Moeller, Mark A. Knepper, Robert.
Figure 2 Brain-infiltrating immune cells mainly consist of CD8+ memory T cells Immunofluorescence staining of brain-infiltrating immune cells. Brain-infiltrating.
Volume 70, Issue 6, Pages (September 2006)
Figure 1 Biomarkers associated with different clinical phases in MS
Figure 2 Brain biopsy Brain biopsy (A) Double staining with anti-aquaporin-4 (AQP4) antibody (dark green) and Luxol fast blue (blue) is shown. Loss of.
Figure Nuclear Nrf2 expression after fumarate therapy A new left occipital fluid-attenuated inversion recovery hyperintense (A), T1 hypointense (B), and.
Volume 61, Issue 4, Pages (April 2002)
Figure 2 Elevated antibody reactivities against myelin and Epstein-Barr virus (EBV) peptides in relapsing-remitting multiple sclerosis (RRMS) and higher.
Isolation of Pathogenic Monoclonal Anti-Desmoglein 1 Human Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies  Ken Ishii, Chenyan Lin,
References Kuby Immunology 7th Edition 2013 Chapter 16 Pages Pages
Figure 2 Overview of the patient's history and immunofluorescence pattern of patient CSF IgG Overview of the patient's history and immunofluorescence pattern.
Diseases Involving Myelin
Figure 1 GABAB expression in the thymus(A–C) Staining of thymus tissue with anti-cytokeratin (A) and anti-GABAB antibody (B, C double immunofluorescence).
Figure 4 Representative images of skin biopsy sample
Fig. 4. Identification of GRP78 as the target antigen of NMO-rAbs ON and ON Identification of GRP78 as the target antigen of NMO-rAbs.
Volume 67, Issue 2, Pages (February 2005)
Volume 83, Issue 1, Pages (January 2013)
Carol M. Herak-Kramberger, Dennis Brown, Ivan Sabolić 
Figure 1 KCTD16 antibodies are associated with an underlying tumour
Volume 28, Issue 2, Pages (February 2008)
Figure 1 VGCC antibody uptake in cerebellar slice culture
Erratum: SLE: translating lessons from model systems to human disease
Figure 4 Confirmatory cohorts to assess MOG-IgG1 assay(A) All 81 aquaporin-4 (AQP4)- seropositive patients (blue) from the Oxford National neuromyelitis.
Figure 1 Kaplan-Meier estimation of time to neuromyelitis optica (NMO) conversion and development of motor disability Kaplan-Meier estimation of time to.
Figure 7 VEGF as a mediator of neuroinflammatory disease
Figure 1 Distribution of MOG IgG antibody in pediatric demyelinating diseases Distribution of MOG IgG antibody in pediatric demyelinating diseases (A)
Serum IgE Autoantibodies Target Keratinocytes in Patients with Atopic Dermatitis  Sabine Altrichter, Ernst Kriehuber, Julia Moser, Rudolf Valenta, Tamara.
Renal albumin absorption in physiology and pathology
Figure 1 Examples illustrating gating strategy for fluorescence-activated cell sorting (FACS)‏ Examples illustrating gating strategy for fluorescence-activated.
Figure 1 Anti-Epstein-Barr virus nuclear antigen-1 IgG quartile antibody status differences in MRI measures Anti-Epstein-Barr virus nuclear antigen-1 IgG.
Figure 1 Central B cell tolerance is compromised in patients with NMOSD. Recombinant antibodies (rIgGs) derived from ... Figure 1 Central B cell tolerance.
Figure Overview of patients with demyelinating diseases, presence of clinical symptoms frequently associated with NMDAR encephalitis, and antibody status.
Figure 2. Detection of KIR4.1 autoantibodies using LIPS
Figure 1. Heat map of antibody binding patterns to glycolipid targets in Guillain-Barré syndrome (GBS) cases and controls Heat map of antibody binding.
Figure 1 Full-length MOG cell-based assay using a serum dilution of 1:160 as a cutoff for positivity (red line in both plots)(A) Myelin olidgodendrocyte.
Significant pathological changes and activation of Nrf2 pathway in the glomeruli of human diabetic nephropathy patients. Significant pathological changes.
Sites and Stages of Autoreactive B Cell Activation and Regulation
Domain 3, comprising the basolateral calyx and the stretch of axon leading to the heminode, selectively expressed NaV channels, KCNQ3, and certain scaffolding.
Figure 3. Verification of GluRd2 as the target antigen of the patient's antineural autoantibodies Verification of GluRd2 as the target antigen of the patient's.
Immunohistochemical determination of TIM-3 expression in ccRCC.
Figure Myelin binding of high-level MBP IgA antibodies from a patient with MS Myelin binding of high-level MBP IgA antibodies from a patient with MS (A)
Presentation transcript:

Harry Irving, Hung Jiew Lee, John Parratt Renal Tubule Antibodies in Multiple Sclerosis and other Neurological diseases Harry Irving, Hung Jiew Lee, John Parratt Discipline of Neurology, The University of Sydney, NSW, Australia, 2006. , Multiple sclerosis (MS) is a debilitating neurological disease characterised by inflammatory lesions scattered throughout the central nervous system (CNS). While the exact cause of MS is unknown, it is generally proposed that the disease is secondary to an autoimmune response against the CNS that is precipitated by complex interactions between environmental and genetic factors. Specifically, autoreactive antibodies have been suggested to play a significant role and various myelin and oligodendrocytic proteins have been listed as possible targets. Currently no CNS autoantibodies have been found to be specific to multiple sclerosis. However, patients with neuromyelitis optica (a demyelinating disease with similarities to MS), have been shown to have disease specific antibodies that react with the water channel aquaporin-4 (AQP-4). AQP-4 autoreactive antibodies bind to stomach, brain and kidney tissue where the molecule is expressed and there is evidence that these antibodies are pathogenic. The current study investigated whether other renal binding autoantibodies occur in MS and other neurological diseases. AIM Determine the frequency of anti-renal proximal tubule antibodies in MS patients. Determine the specific location within proximal tubules where ARTA bind. RESULTS Table 1. Frequency of ARTA in the serum of test groups. METHODS Serum from 126 case patients and 186 controls Indirect immunofluorescence (IIF) was performed on frozen sections of rat renal tissue that had been lightly perfused. - ARTA positivity based on binding intensity score of >++ on a qualitative scale. Indirect immunofluorescence was performed on HK-2 cells (an immortalised human proximal tubule cell line). Doublestaining for Ezrin a marker of microvilli within the brush border and human test serum to determine more specifically the location of the antigenic target of ARTA. RESULTS Figure 2. HK-2 Ezrin v ARTA. Arrowheads indicate ezrin positive microvilli (red). ARTA are present in a granular pattern within the submembrane (green). Nuclei are stained with hoescht (blue). Figure 3. Hk-2 cells v ARTA. Serum binds in a granular submembranous pattern. (A) Binding pattern is not universal with many cells not exhibiting binding at all. (B-D) Examples of ARTA positive HK-2 cells displaying binding within granules under the surface membrane. 2 A A Figure 1. ARTA binding within the proximal tubules of rat renal tissue. Level of ARTA serum was measured in a number of test groups. Above is a representative image of an ARTA positive serum sample with high titre (i.e. >+++). ARTA is present within the apical brush border of proximal tubule cells. 1 50μm A B B C C D Figure Serum from MS patients binds to the renal proximal tubules within the kidneys (Figure 1) ARTA are significantly higher in patients with MS and AE than other groups (p=0.015, Chi-Square with Bonferonni correction) (Table 1) . However, there is no significance in the difference between MS and AE (p>0.05) (Table 1). ARTA positive serum binds beneath the surface of the cell membrane in some cells and not within the microvilli (Figure 2-3). CONCLUSION Current evidence suggests that ARTA are a non-pathogenic, non-specific consequence of neuro-immunological responses. The level of ARTA in healthy control subjects was greater than previously reported. As this study aimed at only identifying frequencies of ARTA within MS and various groups the specificity and identification of the antigenic target was not examined. Further research is required to establish whether ARTA represent a specific autoantibody or if ARTA are the combination of various autoreactive antibodies that bind to separate targets within the renal proximal tubule. References . Goldenberg, M. M. (2012). "Multiple sclerosis review." P T 37(3): 175-184. Nair, A., T. J. Frederick, et al. (2008). "Astrocytes in multiple sclerosis: A product of their environment." Cellular and Molecular Life Sciences 65(17): 2702-2720. AE: Autoimmune encephalitis; ADEM: Acute disseminated encephalomyelitis; AQP-4: Aquaporin-4; CIS: Clinical isolated syndrome; HC: Healthy controls; MS: Multiple Sclerosis; NMO: Neuromyelitis optica, OIND: Other inflammatory neurological disease; OND: Other neurological disease; P: Psychiatric.